On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...